Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran

Benzer Materyaller

• Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
  Yazar:: Marin, Ruxandra-Cristina, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study
  Yazar:: Gori, Andrea, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Effects of ritonavir-boosted protease inhibitors on combined oral contraceptive pharmacokinetics and pharmacodynamics in HIV-positive women
  Yazar:: Barcellos, Teresa, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir
  Yazar:: Song, Ivy, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?
  Yazar:: Hamada, Yohei, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)